CrushSCI.com
144.9Average days
120.5Median days
68Fastest days
297Longest days
462025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

111 days

A Relative Bioavailability Study of Vepdegestrant Tablets in Healthy Adult Participants

Authors
Derek Z. Yang; Kyle T. Matschke; Jennifer A. Winton; Kimberly C. Lee; Yuanyuan Zhang; Weiwei TanShow moreShow less
Affiliations
1. Pfizer Inc., San Diego, USA; 2. Pfizer, Inc., Collegeville, USA; 3. Pfizer, Inc., Groton, USA; 4. Arvinas Operations, Inc., New Haven, USAShow moreShow less
Source PDF DOI Publisher page
113 days

Population Pharmacokinetics of Amikacin in Non-Neonatal Pediatric Patients: A Scoping Review

Authors
Chin Chiang Toh; Mohd Makmor Bakry; Noraida Mohamed Shah; Shamin Mohd SaffianShow moreShow less
Affiliations
1. Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; 2. Department of Pharmacy, Tunku Azizah Hospital, Ministry of Health Malaysia, Kuala Lumpur, MalaysiaShow moreShow less
Source PDF DOI Publisher page
145 days

Investigating the Impact of Calcium Channel Blockers on the Pharmacokinetics of Lapatinib: Possible Role of Cytochrome P450 Enzymes and P-glycoprotein Efflux Transporters

Authors
Mrunal Pradeep Desai; Prajakta Harish Patil; Anithakumari Uttam Singh Rajpurohit; Vullendula Sai Krishna Anand; Jagadish Puralae ChannabasavaiahShow moreShow less
Affiliations
1. Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India; 2. Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, IndiaShow moreShow less
Source PDF DOI Publisher page
200 days

Clinical Relevance of the 516 G>T Polymorphism in CYP2B6 and Its Effects on Efavirenz Concentrations in Patients with HIV and Tuberculosis: A Meta-analysis

Authors
Alexandra Villalpando-Solórzano; Ashley Marieth Ramirez-Díaz; José Giovanni Navarro-Rangel; Yair Lara-Blanco; Genaro Rodríguez-Uribe; José Román Chavez-MéndezShow moreShow less
Affiliations
1. Faculty of Health Sciences Valle de las Palmas, Universidad Autónoma de Baja California, Tijuana, Mexico; 2. Faculty of Medicine and Psychology, Universidad Autónoma de Baja California, Tijuana, MexicoShow moreShow less
Source PDF DOI Publisher page
165 days

Toxicity-Tailored Thresholds of Delayed Methotrexate Elimination in Non-Hodgkin Lymphoma: A Population-Based Approach to Therapy Optimization

Authors
Tuan Fauziah; Ganesh Kasinathan; Teng Keat Chew; Mohd Makmor-Bakry; Yi Lin Lee; Noraida Mohamed Shah; Shamin Mohd SaffianShow moreShow less
Affiliations
1. Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; 2. Hematology Department Hospital Ampang, Ministry of Health Malaysia, Selangor, Malaysia; 3. Hematology Department Hospital Pulau Pinang, Ministry of Health Malaysia, Pulau Pinang, Malaysia; 4. Clinical Research Center Hospital Ampang, Ministry of Health Malaysia, Selangor, MalaysiaShow moreShow less
Source PDF DOI Publisher page
125 days

Population Pharmacokinetics of Intranasal Amiloride in Healthy Volunteers

Authors
Manav Jain; Shaun Kumar; Marco Battaglia; Simon Davies; Joseph Rower; Christopher Reilly; Venkata K. YellepeddiShow moreShow less
Affiliations
1. Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, USA; 2. Parexel International, Sydney, Australia; 3. Department of Psychiatry, University of Toronto, Toronto, Canada; 4. Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City, USA; 5. Center for Human Toxicology, College of Pharmacy, University of Utah, Salt Lake City, USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.